Systematic (IUPAC) name | |
---|---|
Hydroxy-dioxostiborane; (2R,3R,4R,5S)-6-methylaminohexane-1,2,3,4,5-pentol | |
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 133-51-7 |
ATC code | P01CB01 QP51AB01 |
PubChem | CID 64953 |
ChemSpider | 58479 |
ChEMBL | CHEMBL239129 |
Chemical data | |
Formula | Variable |
Mol. mass | Variable |
SMILES | eMolecules & PubChem |
|
|
(verify) |
(what is this?)
Meglumine antimoniate (or meglumine antimonate) is a medicine used for treating leishmaniasis. It is manufactured by Aventis and sold as Glucantime in France, and Glucantim in Italy. It belongs to a group of compounds known as the pentavalent antimonials. It is administered by intramuscular injection.
|